Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.5173
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
0.30
Today|||52-Week Range
5.01
-5.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization23.0K23.0K21.0K21.0K
 
 
 
 
 
 
Operating ExpensesGross Income-23.0K-23.0K-21.0K-21.0K
 
 
 
 
 
General Expenses6.4M7.0M6.0M3.2M
 
 
 
 
 
Research And Development2.7M3.7M2.3M1.1M
 
 
 
 
 
Total Operating Expenses6.4M7.0M6.1M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.4M-7.0M-6.1M-3.2M
 
 
 
 
 
Extraordinary Credit1.1M0.00181.0K2.5M
 
 
 
 
Interest Expense On Debt3.0K0.00--2.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-7.0M-5.9M-3.6M
 
 
 
 
 
Net Income-5.3M-7.0M-5.9M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS827.2K1.0M1.2M1.4M
 
 
 
 
 
Shares To Calculate EPS Diluted827.2K1.0M1.2M1.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.30-$6.90-$5.10-$2.55
 
 
 
 
 
EPS Diluted-$6.30-$6.90-$5.10-$2.55